Publication
United States Corporate Transparency Act off again
The US Corporate Transparency Act (CTA) is a law that requires companies to disclose information on their beneficial owners.
Are you currently exploring investment opportunities in Australia or the Asia Pacific? Norton Rose Fulbright’s sixth major Private M&A Deal Points Study provides unique insights on the trends across the private M&A market to help you to better negotiate upcoming deals in Australia and throughout APAC.
The 2020 study captures data from 51 M&A transactions in Australia with a combined value of close to US$2.15 billion, during the 2019 calendar year. For the first time, this year’s study also includes a longitudinal comparison with previous studies from both the Australian market and markets throughout the APAC region.
To learn more about the findings from our latest study, please contact our M&A team here.
Recent publications
Publication
Newly licensed NHPs to be temporarily exempt from upcoming labelling requirements
Health Canada has published a Notice of Intent to publish a ministerial order to exempt natural health products (NHPs) licensed between June 21, 2025, and June 21, 2028, from labelling requirements that are set to come into force this summer under the Natural Health Products Regulations (NHPR).
Subscribe and stay up to date with the latest legal news, information and events . . .